Invitae announced an acquisition of pathology assets in the Pacific Northwest, extending genetic testing capabilities and forming a long-term agreement with UHealth on August 26, 2025.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Invitae announced an acquisition of pathology assets in the Pacific Northwest, extending genetic testing capabilities and forming a long-term agreement with UHealth on August 26, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Invitae
company in San Francisco, United States
Nothing else this week.
-
LabCorp
clinical laboratory company
-
University of Miami Health System
healthcare organization in Miami, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksIs it the Right Time to Hold Labcorp Stock in Your Portfolio? Labcorp Holdings Inc. LH, or Labcorp, is well-poised to grow in the coming quarters, courtesy of its strategic focus on key specialty are